Co-Administration of Amiodarone Increases Bleeding by Affecting Rivaroxaban Pharmacokinetics in Patients with Atrial Fibrillation

This study aimed to investigate the impact of the drug–drug interaction between rivaroxaban and amiodarone on the clinical outcomes in patients with non-valvular atrial fibrillation (NVAF), focusing on pharmacokinetic and pharmacodynamic (PK/PD) aspects. A prospective study enrolling 174 patients wi...

Description complète

Détails bibliographiques

Auteurs principaux:	Huamin Ding, Zi Wang, Jia Wang, Yao Yao, Chi Zhang, Houwen Lin, Yong Zhou, Zhichun Gu, Qianzhou Lv, Xiaoye Li
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2024-07-01
Collection:	Pharmaceutics
Sujets:	rivaroxaban amiodarone DDI PK/PD bleeding events
Accès en ligne:	https://www.mdpi.com/1999-4923/16/8/1006
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!